VNIM
Vaughan Nelson Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-482,572
| Closed | -$170M | – | 245 |
|
|
2023
Q2 | $170M | Buy |
482,572
+7,122
| +1% | +$2.51M | 1.88% | 13 |
|
|
2023
Q1 | $150M | Sell |
475,450
-2,688
| -0.6% | -$847K | 1.85% | 14 |
|
|
2022
Q4 | $138M | Sell |
478,138
-26,123
| -5% | -$7.54M | 1.79% | 15 |
|
|
2022
Q3 | $146M | Sell |
504,261
-357,332
| -41% | -$103M | 2.11% | 14 |
|
|
2022
Q2 | $243M | Sell |
861,593
-7,024
| -0.8% | -$1.98M | 3.28% | 1 |
|
|
2022
Q1 | $227M | Sell |
868,617
-55,130
| -6% | -$14.4M | 2.57% | 6 |
|
|
2021
Q4 | $203M | Buy |
+923,747
| New | +$203M | 2.08% | 14 |
|